BCAX · Bicara Therapeutics Inc.
$24.92
+0.64 (+2.64%)
At close · Aug 17
Market Cap
$1.61B
Shares
66.17M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-10-03 | — | $150,000,000 | $120,000,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-11 |
Key facts
CIK
2023658
CUSIP
055477103
13F (30d)
171 filings
170 filers
Visit website
Investor relations